195 related articles for article (PubMed ID: 18288378)
1. Plasmidic CpG sequences induce tumor microenvironment modifications in a rat liver metastasis model.
Bertin S; Anjuere F; Gavelli A; Baque P; Soilihi BK; Brossette N; Loubat A; Pierrefite-Carle V
Int J Mol Med; 2008 Mar; 21(3):309-15. PubMed ID: 18288378
[TBL] [Abstract][Full Text] [Related]
2. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
Wattrang E; Berg M; Magnusson M
Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
[TBL] [Abstract][Full Text] [Related]
3. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
Mitsui M; Nishikawa M; Zang L; Ando M; Hattori K; Takahashi Y; Watanabe Y; Takakura Y
J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
[TBL] [Abstract][Full Text] [Related]
4. Antimetastatic effect of CpG DNA mediated by type I IFN.
Hafner M; Zawatzky R; Hirtreiter C; Buurman WA; Echtenacher B; Hehlgans T; Männel DN
Cancer Res; 2001 Jul; 61(14):5523-8. PubMed ID: 11454702
[TBL] [Abstract][Full Text] [Related]
5. The administration of naked plasmid DNA into the liver induces antitumor innate immunity in a murine liver metastasis model.
Yonenaga Y; Mori A; Fujimoto A; Nagayama S; Tachibana T; Onodera H; Uemoto S
J Gene Med; 2007 Apr; 9(4):299-307. PubMed ID: 17397091
[TBL] [Abstract][Full Text] [Related]
6. Cytidine-phosphate-guanosine oligodeoxynucleotides and interferon-alpha-expressing tumor cells effectively induce dendritic cell maturation in vitro.
Hiraide A; Hiroishi K; Ishii S; Eguchi J; Imawari M
Anticancer Res; 2006; 26(1A):211-8. PubMed ID: 16475701
[TBL] [Abstract][Full Text] [Related]
7. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides.
Zelenay S; Elías F; Fló J
Eur J Immunol; 2003 May; 33(5):1382-92. PubMed ID: 12731065
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
[TBL] [Abstract][Full Text] [Related]
9. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
[TBL] [Abstract][Full Text] [Related]
10. Oligodeoxynucleotides containing CpG motifs can induce T cell-dependent arthritis in rats.
Svelander L; Erlandsson Harris H; Lorentzen JC; Trollmo C; Klareskog L; Bucht A
Arthritis Rheum; 2004 Jan; 50(1):297-304. PubMed ID: 14730628
[TBL] [Abstract][Full Text] [Related]
11. Identification of CpG oligodeoxynucleotide sequences that induce IFN-gamma production in canine peripheral blood mononuclear cells.
Kurata K; Iwata A; Masuda K; Sakaguchi M; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2004 Dec; 102(4):441-50. PubMed ID: 15541797
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of intrinsic immunogenicity of reporter and insulin gene therapy plasmids.
Ratanamart J; Huggins CG; Kirby JA; Shaw JA
J Gene Med; 2007 Aug; 9(8):703-14. PubMed ID: 17595049
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular events associated with the antitumor response induced by the cytosine deaminase/5-fluorocytosine suicide gene therapy system in a rat liver metastasis model.
Bertin S; Neves S; Gavelli A; Baqué P; Brossette N; Simões S; Pedroso de Lima MC; Pierrefite-Carle V
Cancer Gene Ther; 2007 Oct; 14(10):858-66. PubMed ID: 17589431
[TBL] [Abstract][Full Text] [Related]
14. CpG DNA and LPS induce distinct patterns of activation in human monocytes.
Hartmann G; Krieg AM
Gene Ther; 1999 May; 6(5):893-903. PubMed ID: 10505115
[TBL] [Abstract][Full Text] [Related]
15. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
Jurk M; Schulte B; Kritzler A; Noll B; Uhlmann E; Wader T; Schetter C; Krieg AM; Vollmer J
Immunobiology; 2004; 209(1-2):141-54. PubMed ID: 15481148
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.
Carpentier AF; Xie J; Mokhtari K; Delattre JY
Clin Cancer Res; 2000 Jun; 6(6):2469-73. PubMed ID: 10873101
[TBL] [Abstract][Full Text] [Related]
17. Role of interferon-gamma during CpG oligodeoxynucleotide-adjuvanted immunization with recombinant proteins.
Rosa DS; Bastos KR; Bargieri DY; Tzelepis F; Nomizo A; Russo M; Soares IS; Rodrigues MM
Vaccine; 2007 Aug; 25(32):6007-17. PubMed ID: 17629370
[TBL] [Abstract][Full Text] [Related]
18. Targeted liposomal delivery of TLR9 ligands activates spontaneous antitumor immunity in an autochthonous cancer model.
Hamzah J; Altin JG; Herringson T; Parish CR; Hämmerling GJ; O'Donoghue H; Ganss R
J Immunol; 2009 Jul; 183(2):1091-8. PubMed ID: 19561111
[TBL] [Abstract][Full Text] [Related]
19. Cytosine-phosphate-guanine (CpG) motifs are sensitizing agents for lipopolysaccharide in toxic shock model.
Cornélie S; Wiel E; Lund N; Lebuffe G; Vendeville C; Riveau G; Vallet B; Ban E
Intensive Care Med; 2002 Sep; 28(9):1340-7. PubMed ID: 12209287
[TBL] [Abstract][Full Text] [Related]
20. Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients.
Molenkamp BG; van Leeuwen PA; Meijer S; Sluijter BJ; Wijnands PG; Baars A; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
Clin Cancer Res; 2007 May; 13(10):2961-9. PubMed ID: 17504997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
